Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation & Differentiation

Irvine, California (Newsworthy.ai) Friday Dec 20, 2024 @ 11:50 AM Pacific —

Dec. 20th, 2024 - Irvine, California --(AINewsworthy)-- Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of regenerative medicine. This patent, granted on October 8th, 2024, provides Lionheart Health, Inc., BioLeonhardt LTP, Valvublator, Inc., EyeCell, EarCell, KidneyCell, BladderCell, CerebraCell, CancerCell and other Leonhardt Ventures LLC spin out startups with exclusive rights to this pioneering patent for bioelectric stem cell homing, proliferation and differentiation control for regenerating tissues and organs and extending healthspan longevity.

Claims include a method of using a bioelectric stimulator to stimulate target tissue of a subject to control stem cell homing, proliferation, or differentiation and/or upregulate expression of at least one protein by the target tissue, wherein the protein is selected from the group consisting of activin, epidermal growth factor (EGF), follistatin, hepatocyte growth factor (HGF), insulin-like growth factor 1 (IGF-1), platelet-derived growth factor (PDGF), receptor activator of nuclear factor kappa-B ligand (RANKL), stromal cell-derived factor 1 (SDF1), tropoelastin, vascular endothelial growth factor (VEGF) and any combination thereof.

This core platform technology is being applied to over 38 applications of use https://leonhardtventures.com/development-pipeline/ including (1) Heart & Cardiovascular, (2) Brain Health, (3) Major Organ Regeneration, (4) Medical Aesthetics and (5) Cancer.

Lionheart Health, Inc. http://www.lionhearthealthstim.com is applying this technology into its products and study protocols for skin and hair regeneration, body toning, sexual health, joint health and healthspan longevity.

BioLeonhardt http://www.bioleonhardt.com, Valvublator, Inc. and AortaCell to heart, heart valve and aorta regeneration.

CerebraCell http://www.cerebracell.com is applying it to applications for stroke and TBI recovery. MemoryStim http://www.memory-stim.com for applications in treating dementia and Alzheimer's in combination with klotho therapy.

PancreaCell, KidneyCell, RegenaLung and LiverCell are applying it to major organ regeneration https://leonhardtventures.com/major-organ-regeneration/. In the case of PancreaCell also as a treatment for diabetes. BladderCell to bladder health.

CancerCell http://www.cancercellinc.com is applying is cancer treatment.

"Being able to recruit stem cells where you want to when you want to in the body and then multiple them and control their differentiation is a major breakthrough in organ regeneration research" stated Dr. Jorge Genovese VP of Bioelectric Research.

About Leonhardt Ventures LLC:

Founded in 1982 Leonhardt Ventures LLC (HJ Leonhardt & Co.) is a long standing leader in the development of medical innovations. Over 600,000 patients have been treated with Leonhardt inventions to date http://www.leonhardtventures.com

Contacts:

Howard J. Leonhardt
Leonhardt Ventures LLC

Lionheart Health, Inc.
1 Kent Court
Mission Viejo, CA 92694
http://www.leonhardtventures.com

http://www.lionhearthealthstim.com

http://www.lionheartongevity.com

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation & Differentiation.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.